Home Biotech Stocks Page 112

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Deconstructing the Lipocine Inc (NASDAQ:LPCN) Complete Response Letter

- June 30, 2016 0

FDA Sees Johnson & Johnson (NYSE:JNJ) Ibrutinib As Promising For cGVHD

- June 30, 2016 0

What Impact Will Epclusa Have On Gilead Sciences, Inc. (NASDAQ:GILD) Revenue?

Andy Parker - June 29, 2016 0

Novartis AG (NYSE:NVS) Betting On Xencor’s Two Drug Candidates With $2.4...

Andy Parker - June 29, 2016 0

Are Markets Finally Starting To See ITI Inc (NASDAQ:ITCI)’s Billion Dollar...

Roger Hannington - June 29, 2016 0

Kitov Pharmaceuticals Holdings Ltd (ADR) (NASDAQ:KTOV) Tanks; Opportunity Ahead of NDA...

- June 29, 2016 1

Pfizer Inc. (NYSE:PFE) Wants You To “Get Old”

Andy Parker - June 28, 2016 0

Who’s Buying Teva Pharmaceutical Industries Ltd (NYSE:TEVA) US Assets?

Andy Parker - June 28, 2016 0

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes...

David Rich - June 27, 2016 1

Innocoll Holdings PLC (NASDAQ:INNL) Could Pick Up Two US Approvals Before...

- June 27, 2016 0

1...111112113...146 Page 112 of 146

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.